CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Prostate cancer resistant to hormone therapy could soon have a new treatment option. The Institute of Cancer Research (ICR), ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

Participation in the 340B Drug Pricing Program does not increase the use of targeted therapy in older patients with advanced prostate cancer, a study suggests.

2024 — Prostate cancer, especially in advanced stages such as castration-resistant prostate cancer, is challenging to treat. Traditional therapies targeting androgen receptor (AR) signaling have ...

—For patients with biochemical recurrent prostate cancer, prostate-specific membrane antigen positron emission tomography has the potential to improve long-term outcomes. A new study tested this ...

Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously ... Dec. 19, 2024 — There are several ...

The limitations of traditional imaging methods drive clinicians to expand the use of advanced imaging techniques in the staging of high-risk prostate cancer. Once such emerging modality is whole ...

Researchers say they have been encouraged by trials of a new process to detect prostate cancer in men. It is hoped that the ...

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical ...

This joint Request for Proposals (RFP) is designed to address critical gaps in patient care for individuals with advanced prostate cancer (APC) and support novel quality improvement, solution ...